Please ensure Javascript is enabled for purposes of website accessibility

Royalty Pharma Willing to Pay More for Elan, Depending on Investor Demands

By Brian Orelli, PhD - Apr 15, 2013 at 5:41PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Purchase price tied to Dutch auction.

Royalty Pharma announced Monday that it's willing increase the $11-per-share offer it made for Elan (ELN) back in February, depending on the result of Elan's buyback.

The biotech recently announced plans to repurchase $1 billion worth of shares through a Dutch auction. As part of the auction, investors are given the option to sell their shares back to the company at a price between $11.25 and $13.00, specified by the shareholder. Elan would then buy back shares at the lowest price that allows it to purchase shares worth $1 billion in aggregate.

Royalty Pharma has tied its offer to the price Elan ends up paying at the Dutch offering. It'll pay the same amount as shareholders were given if the offer is for $11.25 or $11.50. If shareholders demand $11.75 or $12, Royalty Pharma is willing to pay $12 per share for the remaining share of Elan. If shareholders demand more than $12, Royalty Pharma is willing to pay only $11 per share, presumably because it believes at that level Elan is overpaying to buy back its shares.

Royalty Pharma also put a $1-per-share clause in the offer because it doesn't know exactly how much net cash Elan has. If the deal goes through, Elan can confirm that its balance sheet meets the requirements or Royalty Pharma will reduce the offer by $1 per share and pay all or some of that $1 through a net cash right, once it takes control.

Elan acknowledged Royalty Pharma's press release and said it would consider the offer but didn't hint at whether the increase was good enough.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Elan Corporation Limited Stock Quote
Elan Corporation Limited

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/20/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.